Pentacel Vaccine in Limited Supply

Due to a manufacturing delay, sanofi pasteur is temporarily implementing order limitations for Pentacel (DTaP-IPV/Hib) vaccine. During this delay, all Pentacel® orders will be limited to approximately 60-70% of historical average usage. Therefore, we suggest looking at your practice’s monthly usage, and apply this reduction to determine future Pentacel® dose orders. This reduction is effective immediately and will continue until further notice.

View the complete April 27, 2012 Health Advisory here.